Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Heart Failure: A Companion to Braunwald's Heart Disease

See next edition:

Heart Failure
Heart Failure

Heart Failure: A Companion to Braunwald's Heart Disease

9780323609876
902.11 zł
766.79 zł Save 135.32 zł Tax included
Lowest price within 30 days before promotion: 766.79 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Up-to-date, authoritative and comprehensive, Heart Failure, 4th Edition, provides the clinically relevant information you need to effectively manage and treat patients with this complex cardiovascular problem. This fully revised companion to Braunwald’s Heart Disease helps you make the most of new drug therapies such as angiotensin receptor neprilysin inhibitors (ARNIs), recently improved implantable devices, and innovative patient management strategies. Led by internationally recognized heart failure experts Dr. G. Michael Felker and Dr. Douglas Mann, this outstanding reference gives health care providers the knowledge to improve clinical outcomes in heart failure patients.

Product Details
Elsevier
62854
9780323609876
9780323609876

Data sheet

Publication date
2019
Issue number
4
Cover
hard cover
Pages count
760
Dimensions (mm)
216 x 276
Weight (g)
2310
  • Section 1 Basic Mechanisms of Heart Failure
    1. Molecular Basis for Heart Failure
    2. Cellular Basis for Heart Failure
    3. Cellular Basis for Myocardial Regeneration and Repair
    4. Myocardial Basis for Heart Failure: Role of Cardiac Interstitium

    Section 2 Mechanisms of Disease Progression in Heart Failure
    5. Molecular Signaling Mechanisms of the Renin-Angiotensin System in Heart Failure
    6. Adrenergic Receptor Signaling in Heart Failure
    7. Role of Innate Immunity in Heart Failure
    8. Oxidative Stress in Heart Failure
    9. Natriuretic Peptides in HF
    10. Systolic Dysfunction in Heart Failure
    11. Alterations in Ventricular Function: Diastolic Heart Failure
    12. Alterations in Ventricular Structure: Role of Left Ventricular Remodeling and Reverse Remodeling in Heart Failure
    13. Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure
    14. Alterations in the Peripheral Circulation in Heart Failure
    15. Alterations in Kidney Function Associated with Heart Failure
    16. Alterations in Skeletal Muscle in Heart Failure
    17. Alterations in Cardiac Metabolism

    Section 3 Etiological Basis for Heart Failure
    18. Epidemiology of Heart Failure
    19. Heart Failure as a Consequence of Ischemic Heart Disease
    20. Heart Failure as a Consequence of Dilated Cardiomyopathy
    21. The Restrictive and Infiltrative Cardiomyopathies and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
    22. Cardiac Amyloidosis
    23. Heart Failure as a Consequence of Hypertrophic Cardiomyopathy
    24. Heart Failure as a Consequence of Genetic Cardiomyopathy
    25. Heart Failure as a Consequence of Hypertension
    26. Heart Failure as a Consequence of Valvular Heart Disease
    27. Heart Failure as a Consequence of Congenital Heart Disease
    28. Heart Failure as a Consequence of Viral and Nonviral Myocarditis
    29. Heart Failure in the Developing World
    30. Heart Failure and Human Immunodeficiency Virus

    Section 4 Clinical Assessment of Heart Failure
    31. Clinical Evaluation of Heart Failure
    32. Cardiac Imaging in Heart Failure
    33. Biomarkers and Precision Medicine in Heart Failure
    34. Hemodynamics in Heart Failure

    Section 5 Therapy for Heart Failure
    35. Disease Prevention in Heart Failure
    36. Management of Acute Decompensated Heart Failure
    Guidelines
    37. Contemporary Medical Therapy for Heart Failure Patients with Reduced Ejection Fraction
    Guidelines: Management of Heart Failure with a Reduced Ejection Fraction
    38. Management of Arrhythmias and Device Therapy in Heart Failure
    Guidelines
    39. Treatment of Heart Failure with Preserved Ejection Fraction
    Guidelines
    40. Management of Heart Failure in Special Populations: Older Patients, Women, and Racial/Ethnic Minority Groups
    41. Gene and Stem-Cell Based Therapies in Heart Failure
    42. Neuromodulation in Heart Failure
    43. Pulmonary Hypertension
    44. Cardiac Transplantation
    45. Circulatory Assist Devices in Heart Failure
    46. Cardio-Oncology and Heart Failure
    47. Disease Management and Telemedicine in Heart Failure
    48. Management of Comorbidities in Heart Failure
    49. Quality and Outcomes in Heart Failure
    50. Decision Making and Palliative Care in Advanced Heart Failure

See next edition:

Heart Failure
Heart Failure
Comments (0)

  • Frequently purchased together

    No products available